Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression
Open Access
- 9 January 2009
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 58 (4), 813-819
- https://doi.org/10.2337/db08-1515
Abstract
OBJECTIVE: Metabolic syndrome (MetS) has been associated with increased prevalence of aortic valve calcium (AVC) and with increased progression of aortic stenosis. The purpose of this study was to determine whether MetS is associated with increased risks for the development of new (“incident”) AVC or for progression of established AVC as assessed by CT. RESEARCH DESIGN AND METHODS: The relationships of MetS or its components as well as of diabetes to risks for incident AVC or AVC progression were studied among participants with CT scans performed at baseline and at either year 2 or year 3 examinations in the Multi-Ethnic Study of Atherosclerosis (MESA). RESULTS: Of 5,723 MESA participants meeting criteria for inclusion, 1,674 had MetS by Adult Treatment Panel III criteria, whereas 761 had diabetes. Among the 5,123 participants without baseline AVC, risks for incident AVC, adjusted for time between scans, age, sex, race/ethnicity, LDL cholesterol, lipid-lowering medications, and smoking, were increased significantly for MetS (odds ratio [OR] 1.67 [95% CI 1.21–2.31]) or diabetes (2.06 [1.39–3.06]). In addition, there was an increase in incident AVC risk with increasing number of MetS components. Similar results were found using the International Diabetes Federation MetS criteria. Among the 600 participants (10.5%) with baseline AVC, neither MetS nor diabetes was associated with AVC progression. CONCLUSIONS: In the MESA cohort, MetS was associated with a significant increase in incident (“new”) AVC, raising the possibility that MetS may be a potential therapeutic target to prevent AVC development.Keywords
This publication has 53 references indexed in Scilit:
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Cholesterol Feeding Increases C-Reactive Protein and Serum Amyloid A Levels in Lean Insulin-Sensitive SubjectsCirculation, 2005
- A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic StenosisThe New England Journal of Medicine, 2005
- The metabolic syndrome, diabetes, and subclinicalatherosclerosis assessed by coronary calciumJournal of the American College of Cardiology, 2003
- Aortic StenosisThe New England Journal of Medicine, 2002
- Global and societal implications of the diabetes epidemicNature, 2001
- Clinical Factors Associated With Calcific Aortic Valve DiseaseJournal of the American College of Cardiology, 1997
- TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.JCI Insight, 1994
- Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patientsThe American Journal of Cardiology, 1987